Werewolf Therapeutics, Inc. (HOWL)
About Werewolf Therapeutics, Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. It is leveraging the proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. It has one reportable segment, which focuses on the discovery and development of cancer therapeutics.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Net income
- -$60.8M
- Total assets
- $69.4M
- Market cap
- $20.8M
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $0
- Operating expenses
- $60.7M
- Operating income
- -$60.7M
- Income tax
- $0
- Net income
- -$60.8M
- EPS (basic)
- $-1.32
- EPS (diluted)
- $-1.33
Balance sheet
- Total assets
- $69.4M
- Current assets
- $58.6M
- Total liabilities
- $44.6M
- Current liabilities
- $36.1M
- Shareholders’ equity
- $24.8M
Cash flow
- Operating cash flow
- -$60.3M
- Investing cash flow
- $54.3M
- Financing cash flow
- $6.0M
- Net cash flow
- $0
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $20.8M
- EPS (diluted)
- $-1.33
- Shares outstanding
- 44.3M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Apr 30, 2021
Werewolf Therapeutics, Inc. (HOWL) Stock Price
- Reported a net loss of $60.8M.
- Trading 80% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Werewolf Therapeutics, Inc..
Write a review
News about Werewolf Therapeutics, Inc.
News & sentiment via Polygon.io
Werewolf Therapeutics, Inc.: frequently asked questions
Is Werewolf Therapeutics, Inc. an American company?
Werewolf Therapeutics, Inc. is a US-based company headquartered in Watertown, Massachusetts, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Werewolf Therapeutics, Inc. headquartered?
Werewolf Therapeutics, Inc. is headquartered in Watertown, Massachusetts, United States.
Is Werewolf Therapeutics, Inc. publicly traded?
Yes — Werewolf Therapeutics, Inc. is a publicly traded company. Its stock trades under the ticker symbol HOWL on the NASDAQ.
What does Werewolf Therapeutics, Inc. do?
Werewolf Therapeutics, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
